Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Mingyang Li, Hui Zhuang & Lai Wei. (2019) How would China achieve WHO’s target of eliminating HCV by 2030?. Expert Review of Anti-infective Therapy 17:10, pages 763-773.
Read now
Read now
Bei Zhu, Cuiyu Wang, Xiaoli Zhang, Juan He, Jianqing Wu, Rongbin Yu & Weihong Zhao. (2015) Relationships between interleukin-12B and interleukin-10 gene polymorphisms and hepatitis C in Chinese Han hemodialysis patients. Renal Failure 37:3, pages 505-510.
Read now
Read now
Juan He, Xiaohua Pei, Wei Xu, Cuiyu Wang, Xiaoli Zhang, Jianqing Wu & Weihong Zhao. (2011) The Relationship between Tumor Necrosis Factor-α Polymorphisms and Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis. Renal Failure 33:9, pages 915-922.
Read now
Read now
Xiaoli Zhang, Dalan Hu, Bei Zhu, Cuiyu Wang, Juan He, Jianqing Wu, Rong Bin Yu & Wei Hong Zhao. (2011) Tumor Necrosis Factor-α Promoter Gene Polymorphisms Are Not Associated with Hepatitis C Virus Infection in Chinese Hemodialysis Patients. Renal Failure 33:6, pages 593-599.
Read now
Read now
Cuiyu Wang, Jinghua Sun, Bei Zhu, Steven Larsen, Rongbin Yu, Jianqing Wu & Weihong Zhao. (2010) Hepatitis B virus infection and related factors in hemodialysis patients in China – systematic review and meta-analysis. Renal Failure 32:10, pages 1255-1264.
Read now
Read now
Articles from other publishers (33)
M. Jadoul, A.A. Awan, M.C. Berenguer, A. Bruchfeld, F. Fabrizi, D.S. Goldberg, J. Jia, N. Kamar, R. Mohamed, M.G. Pessôa, S. Pol, M.E. Sise & P. Martin. (2022) KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney International 102:6, pages S129-S205.
Crossref
Crossref
Nathalia F. Pestana, Claudia M.A. Equi, Carlos P. Gomes, Ana C. Cardoso, João P. Zumack, Cristiane A. Villela-Nogueira & Renata M. Perez. (2021) Aminotransferase-to-platelet ratio index and Fibrosis-4 index score predict hepatic fibrosis evaluated by transient hepatic elastography in hepatitis C virus-infected hemodialysis patients. European Journal of Gastroenterology & Hepatology 33:1S, pages e260-e265.
Crossref
Crossref
Xue MeiHongzhou Lu. (2021) Prevalence, diagnosis, and treatment of hepatitis C in Mainland China. Global Health & Medicine 3:5, pages 270-275.
Crossref
Crossref
Tiruneh Adane & Solomon Getawa. (2021) The prevalence and associated factors of hepatitis B and C virus in hemodialysis patients in Africa: A systematic review and meta-analysis. PLOS ONE 16:6, pages e0251570.
Crossref
Crossref
Xiaozhong Wang & Lai Wei. (2021) Direct-acting Antiviral Regimens for Patients with Chronic Infection of Hepatitis C Virus Genotype 3 in China. Journal of Clinical and Translational Hepatology 000:000, pages 000-000.
Crossref
Crossref
Mohammad Reza Hedayati-Moghaddam, Hossein Soltanian & Sanaz Ahmadi-Ghezeldasht. (2021) Occult hepatitis C virus infection in the Middle East and Eastern Mediterranean countries: A systematic review and meta-analysis. World Journal of Hepatology 13:2, pages 242-260.
Crossref
Crossref
Kalpesh Gohel & Pravin Borasadia. (2020) Sofosbuvir-Based HCV Treatment in Maintenance Hemodialysis Patients: A Single-Center Study. Transplantation Proceedings 52:6, pages 1684-1686.
Crossref
Crossref
Sohail Akhtar, Jamal Abdul Nasir, Muhammad Usman, Aqsa Sarwar, Rizwana Majeed & Baki Billah. (2020) The prevalence of hepatitis C virus in hemodialysis patients in Pakistan: A systematic review and meta-analysis. PLOS ONE 15:5, pages e0232931.
Crossref
Crossref
Prasanta DEBNATH, Sanjay CHANDNANI, Pravin RATHI, Sujit NAIR, Vinay PAWAR & Qais CONTRACTOR. (2020) COMBINED NS5A & NS5B NUCLEOTIDE INHIBITOR THERAPY FOR PATIENTS WITH CHRONIC HEPATITIS C WITH STAGE 5 CHRONIC KIDNEY DISEASE ON HEMODIALYSIS. Arquivos de Gastroenterologia 57:1, pages 39-44.
Crossref
Crossref
Rati Deshpande, Maria Stepanova, Pegah Golabi, Kimberly Brown & Zobair M. Younossi. (2019) Prevalence, mortality and healthcare utilization among Medicare beneficiaries with Hepatitis C in Haemodialysis units. Journal of Viral Hepatitis 26:11, pages 1293-1300.
Crossref
Crossref
Mohd Azri Mohd Suan, Salmiah Md Said, Poh Ying Lim, Ahmad Zaid Fattah Azman & Muhammad Radzi Abu Hassan. (2019) Risk factors for hepatitis C infection among adult patients in Kedah state, Malaysia: A case–control study. PLOS ONE 14:10, pages e0224459.
Crossref
Crossref
Gaofeng Cai, Hongjie Zheng, Lan Luo, Zhengting Wang, Zhenggang Jiang, Shuangfei Xu, Huakun Lv, Yongdi Chen, Biao Zhou & Chonggao Hu. (2019) Factors Correlating to the Development of Hepatitis C Virus Infection in Hemodialysis Patients—Findings Mainly from Asiatic Populations: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health 16:8, pages 1453.
Crossref
Crossref
Shishen Wang, Yuhui Tao, Yuchun Tao, Jing Jiang, Li Yan, Chong Wang, Yaxuan Ding, Jianxing Yu, Dinghui Zhao, Xiumei Chi, Xiaomei Wang, Ruihong Wu, Xiuzhu Gao, Ying Shi, Yazhe Guan, Yingchun Li, Yanli Xing, Haiyan Sun, Changhua Ta, Chao Wang, Junqi Niu, Jing Meng & Hongqin Xu. (2018) Epidemiological study of hepatitis B and hepatitis C infections in Northeastern China and the beneficial effect of the vaccination strategy for hepatitis B: a cross-sectional study. BMC Public Health 18:1.
Crossref
Crossref
. (2018) KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney International Supplements 8:3, pages 91-165.
Crossref
Crossref
Mandarapu Surendra, Sree Bhushan Raju, Nimmagadda Sridhar, Bangillapati Vijay Kiran, Goli Rajesh, Golla Anvesh & Nallagasu Raju. (2017) Ledipasvir and Sofosbuvir for untreated HCV genotype 1 infection in end stage renal disease patients: A prospective observational study. Hemodialysis International 22:2, pages 217-221.
Crossref
Crossref
Tamer A. Hafez. 2018. Hepatitis C in Developing Countries. Hepatitis C in Developing Countries
191
198
.
M. HARFOUCHE, H. CHEMAITELLY, S. MAHMUD, K. CHAABNA, S. P. KOUYOUMJIAN, Z. AL KANAANI & L. J. ABU-RADDAD. (2017) Epidemiology of hepatitis C virus among hemodialysis patients in the Middle East and North Africa: systematic syntheses, meta-analyses, and meta-regressions. Epidemiology and Infection 145:15, pages 3243-3263.
Crossref
Crossref
Jessica I Bravo Zuñiga, César Loza Munárriz & Jesús López-Alcalde. (2016) Isolation as a strategy for controlling the transmission of hepatitis C virus (HCV) infection in haemodialysis units. Cochrane Database of Systematic Reviews 2016:8.
Crossref
Crossref
Keiko Katayama, Tomoki Sato, Son Huy Do, Hiroko Yamada, Ayako Tabuchi, Yutaka Komiya, Junko Matsuo, Ayumu Nakashima, Masayuki Ohisa, Tomoyuki Akita, Noriaki Yorioka, Yuzo Miyakawa, Hiroshi Yoshizawa & Junko Tanaka. (2015) Hepatitis B virus infection in hemodialysis patients in Japan: Prevalence, incidence and occult hepatitis B virus infection. Hepatology Research 45:12, pages 1211-1219.
Crossref
Crossref
Eugene Kwon, Jang-Hee Cho, Hye Min Jang, Yon Su Kim, Shin-Wook Kang, Chul Woo Yang, Nam-Ho Kim, Hyun-Ji Kim, Jeung-Min Park, Ji-Eun Lee, Hee-Yeon Jung, Ji-Young Choi, Sun-Hee Park, Chan-Duck Kim & Yong-Lim Kim. (2015) Differential Effect of Viral Hepatitis Infection on Mortality among Korean Maintenance Dialysis Patients: A Prospective Multicenter Cohort Study. PLOS ONE 10:8, pages e0135476.
Crossref
Crossref
Digdem Ozer Etik. (2015) Hepatitis C infection in hemodialysis patients: A review. World Journal of Hepatology 7:6, pages 885.
Crossref
Crossref
Mohamed El–Tayeb Nasser, Khaled Mohamed Younes, Dawlat Hussein Sany, Samar Samir Youssef, Mohamed Mahmoud & Bassim Samy El-Sayed. (2014) HCV Seroconversion in two Egyptian Hemodialysis Units: Role of Detection Method and Patients Isolation. Open Access Macedonian Journal of Medical Sciences 2:1, pages 124-127.
Crossref
Crossref
Peter Otorepec, Piedad Martin-Olmedo, Julia Bolivar, Odile Mekel, Jutta Grohmann, Daniela Kállayova, Mária Kvaková, Jana Kollárová, Ágnes Molnár, Balázs Ádám, Stella R. J. Kræmer, Mariusz Geremek, Joanna Kobza & Rainer Fehr. 2014. Assessment of Population Health Risks of Policies. Assessment of Population Health Risks of Policies
131
198
.
Jingxing Wang, Jing Liu, Yi Huang, David J. Wright, Julin Li, Zhongmin Zhou, Weilan He, Tonghan Yang, Fuzhu Yao, Xiangming Zhu, Guoxin Wen, Xinhong Bi, Mei-hei-li Tiemuer, Xiuqiong Wen, Mei Huang, Ru'an Cao, Zhongqiao Yun, Yunlai Lü, Hongli Ma, Nan Guo, Qilu Yu, Paul Ness & Hua Shan. (2013) The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations. Transfusion 53:10pt2, pages 2489-2497.
Crossref
Crossref
Yan Cui & Jidong Jia. (2013) Update on epidemiology of hepatitis B and C in China. Journal of Gastroenterology and Hepatology 28, pages 7-10.
Crossref
Crossref
Yingying Su, Ruixue Yan, Zhongping Duan, Jessie L. Norris, Lu Wang, Yan Jiang, Wenge Xing, Yu Chen, Yao Xiao, Lu Li, Jun Tao & Ning Wang. (2013) Prevalence and risk factors of hepatitis C and B virus infections in hemodialysis patients and their spouses: A multicenter study in Beijing, China. Journal of Medical Virology 85:3, pages 425-432.
Crossref
Crossref
Duan Li, Yong Long, Tingcai Wang, Dan Xiao, Jingxia Zhang, Zhiwen Guo, Bo Wang & Yongping Yan. (2013) Epidemiology of Hepatitis C Virus Infection in Highly Endemic HBV Areas in China. PLoS ONE 8:1, pages e54815.
Crossref
Crossref
F. Fabrizi, V. Dixit & P. Messa. (2012) Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?. Journal of Viral Hepatitis 19:9, pages 601-607.
Crossref
Crossref
Kalyan Debnath & Pradip Bhaumik. (2011) Prevalence of Hepatitis B and C among Hemodialysis
Patients of Tripura, India. Euroasian Journal of Hepato-Gastroenterology 2:1, pages 10-13.
Crossref
Crossref
Bhadran Bose, Stephen P. McDonald, Carmel M. Hawley, Fiona G. Brown, Sunil V. Badve, Kathryn J. Wiggins, Kym M. Bannister, Neil Boudville, Philip Clayton & David W. Johnson. (2011) Effect of Dialysis Modality on Survival of Hepatitis C-Infected ESRF Patients. Clinical Journal of the American Society of Nephrology 6:11, pages 2657-2661.
Crossref
Crossref
Qian Cui, Yong-Xiang Zhang, Jing Su, Xin Chen, Keqin Ding, Na Lei, Yan Liu, Jun Li, Yun Zhang & Rong-Bin Yu. (2011) Genetic variation in IL28RA is associated with the outcomes of HCV infection in a high-risk Chinese population. Infection, Genetics and Evolution 11:7, pages 1682-1689.
Crossref
Crossref
Li Duan, Pan Lei, Xie Yumei, Xue Xiaoping, Zhao Futao, Ma Li, Wei Xin, Wang Jiuping, Bai Xuefan & Jia Zhansheng. (2011) Prediction and identification‐based prediction of Chinese hepatitis C viral‐specific cytotoxic T lymphocyte epitopes. Journal of Medical Virology 83:8, pages 1315-1320.
Crossref
Crossref
Jessica I Bravo Zuñiga, Cesar Loza Munarriz & Jesús López-Alcalde. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.